Insider trade

Cormedix (CRMD): CFO bought ~$23K

Susan Blum, CFO at Cormedix, bought ~$23K of Cormedix shares.

~$23K
Approx. value · 5,000 sh @ $4.58
129K
Holds after · shares reported
Traded
Nov 19, 2026
Filed
Nov 20, 2026

What stands out in this filing

  • 4 CRMD insiders bought within the same week. That happened 6 times before in filings since 2010, most recently May 2023.
  • Susan Blum's first open-market purchase of CRMD in filings since 2010.
  • The purchase added 4.0% to the shares this insider held before it; the filing reports 129,315 shares afterwards.
  • 5,000 shares at an average of $4.58 each, as reported on the form.
  • No other open-market purchase by this insider in 25 months of filings.
  • 3 other insiders at CRMD also bought in the open market within 30 days.

Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Nov 2, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
  2. Nov 8, 2026Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations (and 2 more items)
  3. Nov 12, 2026Company filing · Form 8-K · ResultsReported its results
  4. Nov 13, 2026Insider · First insider buy since Oct 2024CEO purchased ~$391K of CRMD shares in the open market
  5. Nov 16, 2026Insider · Their largest buy since 2016Director purchased ~$122K of CRMD shares in the open market
  6. Nov 18, 2026Insider · 3 insiders in a week, 14th time since 2010Director purchased ~$52K of CRMD shares in the open market
  7. Nov 19, 2026 · this disclosureInsider · 4 insiders in a week, 7th time since 2010CFO purchased ~$23K of CRMD shares in the open market
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Cormedix

For Cormedix, OQRO holds 4 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its CRMD page.

How this filing works

Explore the data

Common questions

Which Cormedix (CRMD) insider traded, and how much?

Susan Blum, CFO at Cormedix, bought ~$23K of Cormedix shares. 5,000 shares at $4.58, open market.

When did it happen, and when was it made public?

Traded: Nov 19, 2026. Filed: Nov 20, 2026. That is 1 day between the two dates.

What stands out in this filing?

4 CRMD insiders bought within the same week. That happened 6 times before in filings since 2010, most recently May 2023. Susan Blum's first open-market purchase of CRMD in filings since 2010. The purchase added 4.0% to the shares this insider held before it; the filing reports 129,315 shares afterwards.

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Cormedix recently?

For Cormedix, OQRO holds 4 insider filings (SEC Form 4 or Form 144) dated in the last 90 days. They are listed on the CRMD page.

Does this mean CRMD stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Cormedix

Everything OQRO holds on this company is on its CRMD page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data